CAS: 64202-81-9 - (8R,9R,12R,13R,14R,16R)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Formula:C28H39N3O8
InChI:InChI=1/C28H39N3O8/c1-14-10-18-23(29)20(32)13-19(25(18)34)31-27(35)15(2)8-7-9-21(37-5)26(39-28(30)36)17(4)12-16(3)24(33)22(11-14)38-6/h7-9,12-14,16,21-22,24,26,33H,10-11,29H2,1-6H3,(H2,30,36)(H,31,35)/b9-7+,15-8-,17-12+/t14-,16-,21-,22-,24-,26-/m1/s1
- Synonyms:
- (10E)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- Ipi-493
IPI-493
CAS:64202-81-9
IPI-493 is a bioactive chemical.
Formula:
C28H39N3O8
Purity:
100%
Color and Shape:
Solid
Molecular weight:
545.62
Ref: TM-T32188
1mg | 274.00 € | ||
5mg | 673.00 € | ||
10mg | 920.00 € | ||
25mg | 1,417.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,572.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
17-Amino Geldanamycin-13C,15N2
Controlled ProductCAS:64202-81-9
Applications The labelled active metabolite of 17-(Allylamino)geldanamycin (17AAG). References Kamal, A., et al.: Nature, 425, …
Formula:
CC27H39N2NO8
Color and Shape:
Neat
Molecular weight:
548.604
Ref: TR-A609702
1mg | 423.00 € | ||
10mg | 2,908.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
17-Amino Geldanamycin
Controlled ProductCAS:64202-81-9
Applications The active metabolite of 17-(Allylamino)geldanamycin (17AAG). References Kamal, A., et al.: Nature, 425, 407 …
Formula:
C28H39N3O8
Color and Shape:
Neat
Molecular weight:
545.62
Ref: TR-A609700
5mg | 1,204.00 € | ||
10mg | 2,039.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
17-Aminogeldanamycin
CAS:64202-81-9
Inhibits chaperone protein Hsp90; antineoplastic
Formula:
C28H39N3O8
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
545.62 g/mol
Ref: 3D-BA17365
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
500µg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025